Craig Hallum reaffirmed their buy rating on shares of Encompass Health (AMEX:EHC) in a report released on Monday morning, The Fly reports. Craig Hallum currently has a $76.00 target price on the stock, down from their prior target price of $81.00.
Other research analysts have also recently issued research reports about the company. Raymond James lowered their target price on Encompass Health from $80.00 to $75.00 and set an outperform rating for the company in a research note on Wednesday, July 31st. Piper Jaffray Companies set a $77.00 target price on Encompass Health and gave the company a buy rating in a research note on Wednesday, July 31st. Zacks Investment Research cut Encompass Health from a hold rating to a sell rating in a research note on Tuesday, July 30th. Barclays upgraded Encompass Health from an equal weight rating to an overweight rating and raised their target price for the company from $68.00 to $70.00 in a research note on Thursday, May 30th. Finally, Royal Bank of Canada restated a buy rating on shares of Encompass Health in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. Encompass Health presently has an average rating of Buy and a consensus price target of $75.14.
Encompass Health has a 1 year low of $40.86 and a 1 year high of $59.29.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.